| Friday 10 July |
| Urban Logistics REIT |
| Monday 13 July |
| Redcentric (re share issue) |
| Starcom |
| Fastforward Innovations |
| City of London Investment Group (re merger with Karpus Management) |
| Renalytix (re proposed Nasdaq dual listing) |
| Mitie (re rights issue) |
| Tuesday 14 July |
| easyJet (re fundraising) |
| Filta Group |
| Great Western Mining |
| Vistry Group (re bonus issue) |
| Itaconix (re fundraise) |
| Shires Income |
| QinetiQ |
| Wednesday 15 July |
| Europa Metals (re share consolidation) |
| Tullow Oil (re stake sale in Albert project) |
| Thalassa Holdings |
| Burberry Group |
| Biotech Growth Trust |
| Air Partner |
| Severn Trent |
| Danakali |
| Thursday 16 July |
| BT Group |
| DCC |
| Electrocomponents |
| Marshall Motors |
| Evgen Pharma |
| Renewi |
| Tiziana Life Sciences |
| Foresight Solar Fund |
| Trackwise Designs |
| Instem |
| Biffa |
| Copyright 2020 Alliance News Limited. All Rights Reserved. |
4 Dec 2019 15:38
Tiziana initiates study of 'Foralumab' in coated capsule form
(Sharecast News) - Clinical-stage biotechnology company Tiziana Life Sciences announced the initiation of a phase 1 clinical trial in healthy volunteers on Wednesday, with a proprietary oral formulation of 'Foralumab' encapsulated in enteric-coated capsules.
Read more